NurExone's ExoTherapy platform enables precise, minimally-invasive delivery of therapies to injured tissues using exosomes as an advanced delivery system. With a growing body of preclinical data and ...

See “From Where I Sit” at UAB’s Alys Stephens Performing Arts Center, at 7 p.m. Saturday, May 10, as part of the UAB ...

Sponsored Level 1 ADR program facilitates trading by US investors following recent FDA clearance and commercial launch BNY ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, and the Christopher & Dana Reeve ...

D modeling for robotic prostatectomyCost comparison of checkpoint inhibitors in high-risk bladder cancerAI-generated prostate ...

Capitalizing on the flexibility of tiny cells inside the body's smallest blood vessels may be a powerful spinal cord repair strategy, new research suggests.

Capitalizing on the flexibility of tiny cells inside the body's smallest blood vessels may be a powerful spinal cord repair ...

面对慢性脊髓损伤患者的麻醉过程，始终要保持警觉。及时识别和处理自主神经反射异常，可以减少术中风险，保护患者的生命安全。请确保在手术前与医生进行充分沟通，了解麻醉的相关指引和注意事项，为手术的顺利进行做好充分准备。通过这些措施，我们能够为脊髓损伤患者提供更安全的手术体验，有效地降低并发症的发生率。 返回搜狐，查看更多 ...

For people with spinal cord injuries/diseases (SCI/D), performing daily tasks can be a challenge due to an impaired ability to grasp and manipulate objects with their hands.

SpineX Inc. Announces Significant Improvement in Urinary Bladder Function in Paralyzed Individuals with SCONE™ Therapy ...

SpineX Inc., a pioneering medical technology company developing innovative non-surgical spinal cord neuromodulation solutions, today announced the results of its global, multisite pivotal trial, ...